Simvastatin

C-reactive protein ; Homo sapiens







89 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 17196684 Strong suppression of high-sensitivity C-reactive protein level and its mediated pro-atherosclerotic effects with simvastatin: in vivo and in vitro studies. 2007 Oct 18 6
52 17239709 Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study. 2007 Jan 23 1
53 17261959 Impact of simvastatin and losartan on antiinflammatory effect: in vitro study. 2007 Jan 2
54 17560879 Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels. 2007 Jun 15 4
55 17719471 Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis. 2007 Aug 28 1
56 17929126 Effects of low-dosage simvastatin on rheumatoid arthritis through reduction of Th1/Th2 and CD4/CD8 ratios. 2007 1
57 18023360 Decreased C-reactive protein-induced resistin production in human monocytes by simvastatin. 2007 Dec 6
58 18219956 [The effects of early application of simvastatin on C-reactive protein level, blood lipids, and the clinical course of acute coronary syndrome]. 2007 2
59 16054696 Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persist. 2006 Mar 3
60 16858354 [Short term simvastatin use in patients with heart failure of ischemic origin. Changes of blood lipids, markers of inflammation and left ventricular function]. 2006 1
61 17145229 Time course of C-reactive protein reduction with simvastatin therapy in patients with type 2 diabetes mellitus. 2006 Dec 15 7
62 17165637 Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study. 2006 Dec 1
63 15777554 Effects of ezetimibe coadministered with simvastatin on C-reactive protein in a large cohort of hypercholesterolemic patients. 2005 Apr 1
64 15883229 Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes. 2005 Jun 1
65 15994744 In vivo and in vitro effects of statins on lymphocytes in patients with Hashimoto's thyroiditis. 2005 Jul 1
66 16113803 Early antithrombotic and anti-inflammatory effects of simvastatin versus fenofibrate in patients with hypercholesterolemia. 2005 Jul 2
67 16265685 Effects of Angiotensin-converting enzyme inhibition and statin treatment on inflammatory markers and endothelial functions in patients with longterm rheumatoid arthritis. 2005 Nov 1
68 16281491 [Effects of aggressive therapy with simvastatin in patients with acute coronary syndrome and initially normal level of LDLP cholesterol on cardiovascular outcomes (LAOKOON). Pilot randomized trial]. 2005 3
69 14715352 Effect of simvastatin on serum C-reactive protein during hormone replacement therapy. 2004 Jan 15 1
70 15050096 C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. 2004 2
71 15184351 Simvastatin combined with ramipril treatment in hypercholesterolemic patients. 2004 Aug 1
72 15193818 Vascular effects of diet and statin in hypercholesterolemic patients. 2004 Jun 2
73 15250255 Effects of simvastain combined with omega-3 fatty acids on high sensitive C-reactive protein, lipidemia, and fibrinolysis in patients with mixed dyslipidemia. 2004 Jun 1
74 15540478 HMG-CoA reductase inhibitors for lowering elevated levels of C-reactive protein. 2004 Aug 15 1
75 12826933 Simvastatin inhibits interleukin-6 release in human monocytes stimulated by C-reactive protein and lipopolysaccharide. 2003 Jun 4
76 14504184 Enhanced interleukin-1beta in hypercholesterolemia: effects of simvastatin and low-dose aspirin. 2003 Oct 7 1
77 14579918 Rapid effects of simvastatin on lipid profile and C-reactive protein in patients with hypercholesterolemia. 2003 Oct 4
78 14612213 Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles. 2003 Oct 1
79 11835933 Effects of simvastatin (40 and 80 mg) on highly sensitive C-reactive protein in patients with combined hyperlipidemia. 2002 Feb 15 1
80 11927515 Statin attenuates increase in C-reactive protein during estrogen replacement therapy in postmenopausal women. 2002 Apr 2 3
81 12046033 Effects of simvastatin on high-sensitivity C-reactive protein and serum albumin in hemodialysis patients. 2002 Jun 1
82 12234946 Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. 2002 Sep 17 2
83 12375804 Inflammatory predictors of mortality in the Scandinavian Simvastatin Survival Study. 2002 Oct 2
84 12398959 Effects of simvastatin on C-reactive protein in mixed hyperlipidemic and hypertriglyceridemic patients. 2002 Nov 1 3
85 12477621 Simvastatin reduces plasma concentration of high-sensitivity C-reactive protein in type 2 diabetic patients with hyperlipidemia. 2002 Nov-Dec 1
86 11182189 Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia. 2001 Feb 2
87 11306519 Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. 2001 Apr 17 2
88 11382718 Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. 2001 May 29 2
89 11472751 C-reactive protein in patients with familial hypercholesterolemia: no effect of simvastatin therapy. 2001 Aug 1